ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...-Satellite-Sessions/Welcome-and-introduction

Date: 26 Sep 2014
Presenter: Joan Carles
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ic-castration-resistant-prostate-cancer-CRPC

Date: 26 Sep 2014
Presenter: Cora Sternberg
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-discussion-When-to-start-treatment-in-mCRPC

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...Satellite-Sessions/Sequencing-considerations

Date: 26 Sep 2014
Presenter: Eleni Efstathiou
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...-drive-the-appropriate-sequencing-of-therapy

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...nical-trial-data-for-daily-clinical-practice

Date: 26 Sep 2014
Presenter: Maria De Santis
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...ndustry-Satellite-Sessions/Summary-and-close

Date: 26 Sep 2014
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...rgeting-the-androgen-axis-in-prostate-cancer

Date: 26 Sep 2014
Presenter: Gerhardt Attard
Resources: Webcast
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer

http://oncologypro.esmo.org/Meeting-Resourc...t-line-chemotherapy-Data-from-two-randomized

AimSince 2004 docetaxel has been the standard first-line chemotherapy for men with mCRPC. The neutrophil to lymphocyte ratio (NLR), a marker of host inflammation has been associated with worse outcomes in several solid tumors.

Date: 27 Sep 2014
Presenter: Robert van Soest
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...resistant-prostate-cancer-mCRPC-patients-pts

AimThe activity of ENZA after prior treatment with both of ABI and docetaxel (D) has been examined in several retrospective studies. However, there are limited data on the efficacy of ENZA following ABI in chemotherapy-naïve mCRPC pts.

Date: 27 Sep 2014
Presenter: Arun Azad
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Prostate Cancer